About 35Pharma
35Pharma is a Healthcare company based in Montreal (Canada) founded in 2021, and was acquired by GSK in February 2026. It designs and develops innovative biologics for unmet medical needs in healthcare. It operates on a B2B model. 35Pharma offers products and services including HS135, HS235, and Ligand Traps. Its focus areas include Life Sciences, Therapeutics Development, Protein Engineering and Ligand Traps. Its legal entity is 35Pharma Inc.
Company details
35Pharma is a biopharmaceutical company that designs and develops biologics targeting the TGF-beta superfamily for diseases like pulmonary hypertension and obesity. It combines protein engineering expertise with rigorous manufacturing processes to create potent ligand traps. Based in Montreal, Canada, the company advances therapies through clinical trials and partnerships, aiming to improve patient outcomes with a focus on urgent medical needs.
- Headquarters Montreal, Canada
- Stage Acquired
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Website 35pharma.com
- Acquired by GSK (Feb 2026)
- Legal Name 35Pharma Inc.
Products & Services of 35Pharma
35Pharma offers a comprehensive portfolio of products and services, including HS135, HS235, and Ligand Traps.
Therapeutic for treating pulmonary hypertension and related diseases
Therapeutic for cardiometabolic disease and obesity management
Protein-based traps neutralizing pathological factors in diseases
Investors in 35Pharma
35Pharma has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include GSK.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Developer of pharmaceuticals and vaccines for various therapeutic areas | 1715 | gsk.com | Brentford, United Kingdom |
Investor details for 35Pharma
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of 35Pharma
13 people are tracked at 35Pharma (10 in leadership, 3 in team).
| Name | Role | Group |
|---|---|---|
George Georges | Chief Medical Officer | Leadership |
Julie Bédard | Senior Director, Clinical Operations | Leadership |
Ilia A. Tikhomirov | Chief Executive Officer | Leadership |
Thomas Loisel | Vice President Of Manufacturing | Leadership |
Thomas P. Loisel | Vice President Of Manufacturing | Leadership |
Monique Champagne | Vice President Clinical Operations | Leadership |
Julia Schoelermann | Vice President Corporate Development | Leadership |
Maureen O’connor | Chief Scientific Officer | Leadership |
Gilles Tremblay | Vice President Preclinical Development | Leadership |
Dan Chiche | Chief Medical Officer | Leadership |
Sarya Aziz | Program Manager, Clinical & Regulatory Operations | Team |
Claire Viallard | Scientist, Translational Science | Team |
Guillaume Lemieux | Associate Project Manager | Team |
Complete people profiles for 35Pharma
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of 35Pharma
2 dated milestones of 35Pharma across 5 years, from founding to its latest funding, stage changes and deals.
- Founded 35Pharma is founded.
- Exit Acquired by GSK.
Web traffic of 35Pharma
Websites that share an audience with 35Pharma (35pharma.com).
Websites whose visitors overlap most with 35Pharma. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| innodemneurosciences.com | 82% | 1.4K | View details |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about 35Pharma
35Pharma was founded in 2021.
35Pharma is headquartered in Montreal, Canada. It is registered at Montreal, Quebec, Canada.
35Pharma is a biopharmaceutical company that designs and develops biologics targeting the TGF-beta superfamily for diseases like pulmonary hypertension and obesity. It combines protein engineering expertise with rigorous manufacturing processes to create potent ligand traps. Based in Montreal, Canada, the company advances therapies through clinical trials and partnerships, aiming to improve patient outcomes with a focus on urgent medical needs.
35Pharma offers HS135, HS235, and Ligand Traps.
35Pharma has 1 investor. Key investors include GSK.
35Pharma operates through 35Pharma Inc..
Yes. 35Pharma was acquired by GSK in February 2026.
